Inclusive body treatments

---

Earwax trouble? We can help

The safest and easiest way to get rid of excess or stubborn earwax is to see a professional. Larbert Aesthetic Clinic Ltd now offer earwax removal services by our trained and accredited healthcare professional.

£60 for 1 or 2 ears. No wax, no charge

Things to note about safety

Give us a call to speak to an audiologist before your appointment if you’ve experienced any of the following:

• Any pain within the last 90 days• Any middle ear infections within the last 90 days• Any current or recurrent ear infection• Any past operations in or around the ear• Suspect you have any foreign bodies in the ear canal• Suspect you have a perforated eardrum• Any fluid or discharge from inside your ear within the last 90 days.

If you’re not sure you have wax in your ears, give your store a call for a triage appointment first.

Please do not come into store if you, or anyone in your household:

• Are experiencing symptoms of COVID-19• Are required to isolate after travelling• Have been contacted from NHS Test and Trace

During your appointment, you might be required to wear a mask to reduce any risk of transmission.

Softening the wax for your appointment

It may take more than one attempt to remove your wax. It’s important that the wax has been softened to make the procedure as comfortable and effective as possible – so to prepare for your appointment, we’d recommend using olive oil to soften it.

A spray known an Earol is ideal for this. Read the instructions leaflet carefully and use for 7-10 days between 2-4 times daily before your appointment. Other sprays or drops are not always suitable and may prevent us from being able to carry out the removal.

Your ears might feel more blocked up after using olive oil and might reduce your hearing – this is because the wax will soak up the oil.

If you wear hearing aids, avoid wearing them after you put olive oil in your ears as you could damage your hearing aids (which wouldn’t be covered by your warranty).

If you experience a foul taste after using olive oil, stop using it as this might be a sign that there is a hole in your eardrum. If this happens, get in touch with your GP and let us know.

For some people, olive oil use might cause some mild discomfort or irritation. If you have any doubts or concerns, just give us a call or speak to your GP or pharmacist.

What is Saxenda®?

Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weighta (BMI ≥27) who also have weight-related medical problems or obesityb (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie diet and increased physical activitySaxenda® and Victoza®  have the same active ingredient, liraglutide, and should not be used together or with other GLP-1 receptor agonist medicines.

• It is not known if Saxenda®  is safe and effective when taken with other prescription, over-the-counter medicines, or herbal weight-loss products.• It is not known if Saxenda®  is safe and effective in children under 12 years of age.• It is not known if Saxenda®  is safe and effective in children aged 12 to 17 years with type 2 diabetes.

Important Safety Information

Do not share your Saxenda® pen with others even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

What is the most important information I should know about Saxenda®?

Serious side effects may happen in people who take Saxenda®, including:

Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Do not use Saxenda® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Who should not use Saxenda®?

Do not use Saxenda® if:

• you or any of your family have ever had MTC or if you have MEN 2.• you are allergic to liraglutide or any of the ingredients in Saxenda®.• you are pregnant or plan to become pregnant. Saxenda® may harm your unborn baby.

Before taking Saxenda®, tell your health care provider about all of your medical conditions, including if you:

• are taking certain medicines called GLP-1 receptor agonists.• have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.• have or have had problems with your pancreas, kidneys or liver.• have or have had depression or suicidal thoughts, or mental health issues.• are breastfeeding or plan to breastfeed. It is not known if Saxenda® passes into your breast milk. You and your health care provider should decide if you will use Saxenda® or breastfeed.

Tell your health care provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, and herbal supplements. Saxenda® slows stomach emptying and can affect medicines that need to pass through the stomach quickly. Saxenda® may affect the way some medicines work and some other medicines may affect the way Saxenda® works. Tell your health care provider if you take diabetes medicines, especially insulin and sulfonylurea medicines.

How should I use Saxenda®?

• Inject your dose of Saxenda® under the skin (subcutaneously) in your stomach area (abdomen), upper leg (thigh), or upper arm, as instructed by your health care provider. Do not inject into a vein or muscle.

What are the possible side effects of Saxenda®?

Saxenda® may cause serious side effects, including:

• inflammation of the pancreas (pancreatitis). Stop using Saxenda® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your stomach area (abdomen) to your back.• gallbladder problems. Saxenda® may cause gallbladder problems, including gallstones. Some gallbladder problems need surgery. Call your health care provider if you have any of the following symptoms: pain in your upper stomach (abdomen), fever, yellowing of your skin or eyes (jaundice), or clay-colored stools.• increased risk of low blood sugar (hypoglycemia) in adults with type 2 diabetes who also take medicines to treat type 2 diabetes such as sulfonylureas or insulin.• risk of low blood sugar (hypoglycemia) in children who are 12 years of age and older without type 2 diabetes.• Signs and symptoms of low blood sugar may include: shakiness, sweating, headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, and feeling jittery. You should check your blood sugar before you start taking Saxenda® and while you take Saxenda®.• increased heart rate. Saxenda® can increase your heart rate while you are at rest. Your health care provider should check your heart rate while you take Saxenda®. Tell your health care professional if you feel your heart racing or pounding in your chest and it lasts for several minutes.• kidney problems (kidney failure). Saxenda® may cause nausea, vomiting, or diarrhea leading to loss of fluids (dehydration). Dehydration may cause kidney failure, which can lead to the need for dialysis. This can happen in people who have never had kidney problems before. Drinking plenty of fluids may reduce your chance of dehydration. Call your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away, or if you cannot drink liquids by mouth.• serious allergic reactions. Stop using Saxenda® and get medical help right away if you have any symptoms of a serious allergic reaction including swelling of your face, lips, tongue, or throat, fainting or feeling dizzy, very rapid heartbeat, problems breathing or swallowing, or severe rash or itching.• depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes, in your mood, behaviors, thoughts, or feelings. Call your health care provider right away if you have any mental changes that are new, worse, or worry you.

The most common side effects of Saxenda® in adults include nausea, diarrhea, constipation, vomiting, injection site reaction, low blood sugar (hypoglycemia), headache, tiredness (fatigue), dizziness, stomach pain, and change in enzyme (lipase) levels in your blood. Additional common side effects in children are fever and gastroenteritis.

Please click here for Prescribing Information and Medication Guide for Saxenda®. 

Saxenda® is a prescription medication.

Before you choose to use the services of practitioner: Jennifer Bodman BSc, RGN,SPQ,NISP, Post Grad Cert Aesthetic Medicines, please read the following information FULLY AND CAREFULLY: 

Why Saxenda (liraglutide 3mg) injections? The main benefits may include: 

1. Saxenda (Liraglutide) is 97% similar to natural human GLP-1 and therefore acts as a physiological regulator of appetite and thereby reducing food intake by reducing feelings of hunger and increasing feelings of fullness/satiety. The exact underlying mechanism of action is not entirely clear. 2. Saxenda (Liraglutide 3mg injection) is a newly licensed medication indicated for reduction in appetite as an adjunct to a reduced-calorie diet and increased physical activity for weight management of patients with an increased Body Mass Index (BMI). 3. For long term success the treatment needs to be combined with lifestyle changes including nutritional, excercise and behavioural habits. Access to support modules are given through the WeightJourney online service. 4. Weight loss can lead to secondary benefits by improving weight loss related health problems such as cardiovascular risk factors (including hypertension, blood glucose levels and waist circumference) and physical health-related Quality of Life. 

I understand that I have the right to be informed of the procedure, any feasible alternative options, and the risks and benefits. Except in emergencies, procedures are not performed until I have had an opportunity to receive such information and to give my informed consent.

Since every human being is unique, we cannot guarantee any specific result from Saxenda treatment. Medication and or medical conditions may have a negative impact on the outcomes as well as lifestyle factors. Treatment should be discontinued after 12 weeks on the full 3mg/day dose if the patient has not lost at least 5% of their initial body weight. The minimum recommended duration of therapy is 4 weeks of dose escalation followed by 12 weeks of full dose therapy in cases with no contraindications or side- effects of ongoing treatment. If escalation to the next dose step is not tolerated for 2 consecutive weeks, discontinuation of treatment should be considered. Daily doses higher than 3.0 mg are not recommended.

Patients need to follow the instructions carefully as provided separately in the patient instruction sheet. 

Patients must agree to notify their practitioner of any contraindications or side effects of the treatment. 

We will write to your GP to notify them of details of the program and any blood results (if completed).

It is essential to engage with the 2 weekly telephone review and monthly face-to-face reviews with your doctor throughout the treatment program.  

HEALTH CONCERNS: If you suffer from a medical or pathological condition, you need to consult with an appropriate healthcare provider such as your GP or Consultant. If you are under the care of another healthcare provider, it is important that you inform your other healthcare providers of your use of Saxenda (Liraglutide). 

If you are using medications of any kind, you are required to alert practitioner Jennifer Bodman to such use, as well as to discuss any potential interactions between medications and nutritional products with your pharmacist. 

Note:If you have any physical or emotional reaction to SaxendaTreatment, discontinue use immediately, and contact your PRACTITIONER to ascertain if the reaction is adverse or an indication of the natural course of the body’s adjustment to thetreatment. 

Laboratory testing will be done to any patient identified at risk to determine areas of dysfunction, not to diagnose or treat. Potential blood tests: 

5. Full blood count 6. 2. Liver function test 

3. Kidney Function Tests

4. Cholesterol levels, HbA1c, Glucose 

Patient groups who may require blood test monitoring at additional cost: 

• Age 50 or above • High blood pressure • Diabetics • Any significant medical problem 

COMMUNICATION: Every client is an individual, and it is not possible to determine in advance how your system will react to the treatment. It is sometimes necessary to adjust your program as we proceed.. It is your responsibility to do your part by following healthy dietary guidelines, exercise your body and make necessary behavioral modifications. 

You should request your other healthcare provider, if any, to feel free to contact practitioner Jennifer Bodman for answers to any questions they may have regarding the treatment. 

I understand that: 

7. Alternatives to Saxenda therapy are surgical procedures, oral medical treatments (including
Orlistat) and / or dietary and lifestyle changes alone.
8. Several weeks to months of treatment may be required depending on your individual response.
9. If a missed dose is more than 12 hours late, the missed dose should not be taken and the next dose should be taken at the normal time. 10. It is essential to combine eating, exercise and behavioral modifications with Saxenda.

 5. Saxenda should not be used in combination with another GLP-1 receptor agonist, 

insulin or insulin secretagogues (such as sulfonylureas) due to the risk of 

hypoglycaemia. 

 6.Upon initiation of liraglutide treatment in patients on warfarin or other coumarin derivatives more 

frequent monitoring of International Normalised Ratio (INR) is recommended. 

7. Saxenda® causes a delay of gastric emptying, and has the potential to impact the absorption of 

concomitantly administered oral medications. Monitor for potential consequences of delayed absorption     

of oral medications concomitantly administered with Saxenda® 

8. There are several special warnings and precautions for use of Saxenda including warnings on 

pancreatitis, cholelithiasis and cholecystitis, thyroid disease, heart rate, dehydration and hypoglycaemia 

in people with type 2 diabetes. 

9. Thyroid adverse events, such as goitre have been reported in particular in patients with pre-existing 

 thyroid disease. Saxenda should therefore be used with caution in patients with thyroid disease. 

10.A higher rate of cholelithiasis and cholecystitis (gallstone and gallbladder disease) has been 

 observed in patients treated with liraglutide. Cholelithiasis and cholecystitis may lead to 

 hospitalisation and cholecystectomy (surgery to remove the gallbladder). Patients should be aware of the   

 characteristic symptoms of cholelithiasis and cholecystitis. 

11. Signs and symptoms of dehydration, including renal impairment and acute renal failure, have been 

reported in patients treated with Liraglutide. Patients treated with liraglutide should be advised of the 

potential risk of dehydration in relation to gastrointestinal side effects and take precautions to avoid 

 fluid depletion. Patients should also be aware of the symptoms of increased heart rate. 

12.Acute pancreatitis has been observed with the use of Liraglutide.Patients and their carers should be told  

 how to recognise signs and symptoms of acute pancreatitis and advised to seek immediate   

medical attention if symptoms develop. If pancreatitis is suspected, liraglutide should be 

 discontinued; if acute pancreatitis is confirmed, liraglutide should not be restarted. 

13.Liraglutide may cause dose-dependent and treatment-duration-dependent thyroid C-cell tumors at  

clinically relevant exposures in both genders of rats and mice. It is unknown whether Saxenda® causes  

 thyroid C-cell tumors, including medullary thyroid carcinoma (cancer, MTC), in humans, as the human   

relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined. Patients should be 

aware of symptoms of thyroid tumours (such as a mass in the neck,difficulty swallowing, difficulty  

breathing or shortness of breath, persistent hoarseness).

The Most Common Saxenda side Effects are :

• Nausea.      Hypoglycaemia   vomiting.   Dyspepsia.    abdominal pain    Constipation.  Diarrhoea    headache    fatigue       increased lipase      Decreased appetite.                   Dizziness    

Risks of Saxenda treatment include but not limited to: 

Common or very common, reported in ≥5%: Dysgeusia (altered sense of taste), dry mouth, insomnia, asthenia; burping; constipation; diarrhoea; dizziness; dry mouth; gallbladder disorders; gastrointestinal discomfort; gastrointestinal disorders; insomnia; nausea; vomiting, 

hypoglycaemia, dyspepsia, gastritis, gastro-oesophageal reflux disease, flatulence, eructation, upper abdomen pain, abdomen distension, cholelithiasis, injection site reactions, fatigue, increased lipase and inceased amylase.

Uncommon: Malaise; pancreatitis; tachycardia; urticaria  

Rare: Renal impairment, allergic reaction, anaphylaxis 

Summary of Saxenda Side effects:

Organ classes    | Very common (≥5%)   | Common                     | Uncommon               |Rare 

Immune system  Anaphylactic 

                                                                                                                                           Reaction Metabolism

nutrition                                                  | Hypoglycaemia.                 Dehydration 

Psychiatric                                              | Insomnia (3 months)

Nervous system                                      | Dizziness 

                                                                | Dysgeusia 

                                                                | (Altered sense of taste) 

Cardiac                                                                                                     Tachycardia

Gastrointestinal.           Nausea                         Dry Mouth                              Pancreatitis

Vomiting                   Dyspepsia

Diarrhoea                  Gastritis

Constipation               Gastro-Oesopageal 

                                                                     Reflux Disease

Abdominal pain upper 

Flatulence/Burping 

Eructation 

 Abdominal distension 

Hepatobiliary   Cholelithiasis   Cholecystitis 

Skin & subcutaneous   Urticaria

Renal & Urinary.                                                                                                               Acute renal 

 failure 

 Renal  

 impairment

General & admin sites  Injection site reactions

Asthenia
Fatigue   Malaise 

Investigations  Increased lipase

 Increased amylase 

Do not take Saxenda if any of the below contraindications apply to you: 

• Aged under 18 or above 75 • Severe renal/kidney impairment (with eGFR of 30 or below) or a history of renal disease • Severe hepatic/liver impairment • Personal or family history of medullary thyroid cancer (MTC) • Hypersensitivity to Saxenda (Liraglutide) or to any of the excipients: disodium phosphate dihydrate, propylene glycol, phenol and water for injection. • Concurrent treatment with any other products for weight management• Weight problems related to endocrinological or eating disorders• Concurrent insulin or sulfonyuria• Patients on warfarin (more frequent INR monitoring required)• Concurrent use of any medicinal products with may cause weight gain• Pregnancy, breastfeeding or trying to/planning to become pregnant.• Congestive heart failure New York Heart Association (NYHA) class IV• History of pancreatitis, gallbladder disease, inflammatory bowel disease, diabetic gastroparesis. • Patients with a personal or family history of MEN 2 (Multiple Endocrine Neoplasia syndrome). 

The below drugs interact with Saxenda and treatment of Saxenda should not be used concurrently.

Drug interactions: 

Acarbose   Exenatide   Linagliptin

Alogliptin   Glibenclamide  Lixisenatide 

Biphasic insulin aspart   Gliclazide   Metformin
Biphasic insulin lispro   Glimepiride  Nateglinide
Biphasic isophane insulin.     Glipizide   Pioglitazone
Canagliflozin  Any insulin including aspart,  Repaglinide
Dapagliflozin                          degludec, detemir, glargine,   Saxagliptin, Dulaglutide                            glulisine, lispro, isophane, zinc  Sitagliptin, Empagliflozin                         suspension   Vildagliptin

 Tolbutamide 

4 weeks dose escalation schedule 

Maintenance dose: 3.0 mg

ENDYMED 3DEEP™ RADIOFREQUENCY

EndyMed 3DEEP™ radiofrequency technology uses focused RF to rejuvenate and create strong collagen and elastin fibers which result in tighter, smoother skin for all skin types.

This treatment is so popular we had to purchase a second machine to meet demand. That's because EndyMed, combined with our highly trained team, are achieving wonderful skin rejuvenation results with minimum discomfort and downtime.

WHAT IS SPECIAL ABOUT THE ENDYMED?

EndyMed uses controlled, focused radiofrequency, through 3 distinct treatment methods, to stimulate your skin's natural rejuvenation process to achieve natural looking, and long lasting, results.

• EndyMed TIGHTEN: Tightens mild skin laxity to reduce fine lines and wrinkles on your face, jowls and neck.  • EndyMed INTENSIF: Deep dermal rejuvenation to redefine facial features by tackling deeper lines.• EndyMed SHAPER:  Firms and tightens loose skin on your body.

Endymed Tighten

TIGHTEN's radio-frequency gently heats your dermal cells to rejuvenate existing collagen and produce new collagen. This improves the underlying structure of your skin for a skin tightening results which is most effective for:

Face and Neck

• Tightens lax skin in your cheek, jowl and neck to smooth wrinkles.

Eye Contour

• Tightens skin in the eye contour area, under the eye and above the brow to smooth wrinkles.

V-Shape

• Tightens skin to correct loss of definition along the jawline and chin.

What happens in a treatment?

During a treatment the radiofrequency handpiece is continuously moved in circular movements over the treatment area. A gentle gel is used to aid the movement.  The focused radiofrequency energy heats your skin at the correct depth to contract existing collagen and stimulate the production of new collagen. The treatment feels like having a hot stone massage, so you should find it to be comfortable and relaxing. Immediately afterwards your skin will appear red, like a hot flush, and you will see an immediate tightening of your skin . You can return to work or social engagements after treatment.

However, this post treatment response only lasts up to 2 days. With subsequent, repeated treatments you will build the long lasting result as more collagen is produced. Full results are seen 3-4 months after a course of 6 treatments. Results can last 1-2 years 

Endymed Shaper

depending upon your lifestyle and you can maintain your results with a top-up treatment every 3-6 months.

SHAPER is similar to TIGHTEN, but is designed for body areas. SHAPER is most effective at:

• Firming and tightening loose skin folds on body areas like the tummy, flanks, bottom, décolleté, and upper arms.• It is good for helping patients who have lost weight, but who have been left with mild skin laxity.

What happens in a treatment?

This treatment is comfortable and relaxing, feeling similar to a hot stone massage. The SHAPER handpiece is continuously moved in circular movements over the body area. The focused heat, penetrates even deeper than TIGHTEN, in order to be effective on those problem body areas - by stimulating collagen production to improve the underlying structure of your body's skin.

It takes longer for the results to show on the body than on the face, so you won't see results immediately. Full results are seen 6 months, after a course of 6 treatments, which can last 1-2 years depending upon your lifestyle. You can maintain your results with top-up treatments every 3-6 months.

ENDYMED INTENSIF

INTENSIF provides intensive, dermal rejuvenation by delivering a uniformly distributed radiofrequency deep into your skin’s dermis using tiny micro-needles. This combination treatment stimulates a dramatic response in your skin where the treated tissue, over time, is replaced with new, brighter healthier skin. INTENSIF is most effective when targeting:

• Deep lines and wrinkles on the face and neck.• Acne or trauma scars and stretch marks.

What happens in a treatment?

This treatments requires a course of 3 treatments spaced 4-6 weeks apart.

For comfort, a topical anesthetic is applied before your treatment. The INTENSIF handpiece will then be applied to your skin, and moved across the treatment area in a regular pattern. After treatment a soothing gel will be applied to your skin to aid recovery.

Immediately after treatment your skin will be red, warm and slightly swollen, which will resolve within 2 days. You may develop micro-crusting, which will resolve in 5 days.

You will start to see an improvement to your skin complexion and skin tightening after 14 days which will progressively improve with every treatment. Results can last 1-2 years depending upon your lifestyle and you can maintain your results with a top-up treatment every 6-9 months.

You can further improve your results with an advanced combination treatment, developed by our clinical director, using INTENSIF and PRP to deliver amazing improvements in ageing skin texture, tone and scar reduction.